Frank Atkins

Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid Cancer

Joanna Kłubo-Gwieździńska, Douglas Van Nostrand, Frank Atkins et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 124 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Phase I and Pharmacokinetic Study of the Novel MDR1 and MRP1 Inhibitor Biricodar Administered Alone and in Combination With Doxorubicin

Ronald A. Peck, Jan Hewett, Matthew W. Harding et al. · Journal of Clinical Oncology · 2001 · 107 citations

Medicine, Oncology, Pharmacology +14

The Utility of Radioiodine Scans Prior to Iodine 131 Ablation in Patients with Well-Differentiated Thyroid Cancer

Douglas Van Nostrand, Martha Aiken, Frank Atkins et al. · Thyroid · 2009 · 91 citations

Medicine, Nuclear Medicine, Radiology +17

¹²⁴ I Positron Emission Tomography Versus ¹³¹ I Planar Imaging in the Identification of Residual Thyroid Tissue and/or Metastasis in Patients Who Have Well-Differentiated Thyroid Cancer

Douglas Van Nostrand, Shari Moreau, Varalakshmi Bandaru et al. · Thyroid · 2010 · 89 citations

Medicine, Nuclear Medicine, Radiology +17

Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in the Identification of Metastasis in Differentiated Thyroid Cancer with ¹³¹I Planar Whole-Body Imaging and ¹²⁴I PET

Douglas Van Nostrand, Gauri Khorjekar, Jeff O'Neil et al. · Journal of Nuclear Medicine · 2012 · 56 citations · Full text

Medicine, Nuclear Medicine, Oncology +17